PRPF39 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.893200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.543610E-01
Normal-vs-Stage2
2.918800E-01
Normal-vs-Stage3
1.725230E-01
Normal-vs-Stage4
1.487400E-01
Stage1-vs-Stage2
4.945400E-01
Stage1-vs-Stage3
3.248100E-02
Stage1-vs-Stage4
3.926000E-01
Stage2-vs-Stage3
6.574400E-02
Stage2-vs-Stage4
5.910600E-01
Stage3-vs-Stage4
2.689000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.952600E-01
Normal-vs-AfricanAmerican
2.263200E-01
Normal-vs-Asian
2.719600E-01
Caucasian-vs-AfricanAmerican
2.306000E-01
Caucasian-vs-Asian
5.659000E-01
AfricanAmerican-vs-Asian
5.075800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.931800E-01
Normal-vs-Female
2.881800E-01
Male-vs-Female
8.431200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.130800E-01
Normal-vs-Age(41-60Yrs)
3.262200E-01
Normal-vs-Age(61-80Yrs)
2.769000E-01
Normal-vs-Age(81-100Yrs)
2.593800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.148400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.318800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.572200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.148990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.606820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.640400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.796600E-01
Normal-vs-Daily Drinker
2.674200E-01
Normal-vs-Weekly Drinker
2.607400E-01
Normal-vs-Occasional Drinker
3.074600E-01
Normal-vs-Social Drinker
3.137600E-01
Non Drinker-vs-Daily Drinker
7.584200E-01
Non Drinker-vs-Weekly Drinker
6.469200E-01
Non Drinker-vs-Occasional Drinker
6.462200E-01
Non Drinker-vs-Social Drinker
5.530600E-01
Daily Drinker-vs-Weekly Drinker
8.659200E-01
Daily Drinker-vs-Occasional Drinker
5.133400E-01
Daily Drinker-vs-Social Drinker
4.370800E-01
Weekly Drinker-vs-Occasional Drinker
4.682400E-01
Weekly Drinker-vs-Social Drinker
3.916200E-01
Occasional Drinker-vs-Social Drinker
9.159600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.416100E-02
Normal-vs-Grade 2
1.685810E-02
Normal-vs-Grade 3
3.524300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.405400E-01
Grade 1-vs-Grade 3
9.199600E-01
Grade 1-vs-Grade 4
8.416100E-02
Grade 2-vs-Grade 3
8.892000E-01
Grade 2-vs-Grade 4
1.685810E-02
Grade 3-vs-Grade 4
3.524300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.432400E-01
Normal-vs-NonDiabetic
2.971400E-01
Diabetic-vs-NonDiabetic
6.328200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.291800E-01
Normal-vs-NoPancreatitis
2.778800E-01
Pancreatitis-vs-NoPancreatitis
7.229800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.882800E-01
Normal-vs-N1
2.885600E-01
N0-vs-N1
9.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.929000E-01
Normal-vs-TP53-NonMutant
3.387600E-01
TP53-Mutant-vs-TP53-NonMutant
2.970400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
